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Abstract
Colchicine has been reported to destroy ganglion cells (GCs) in the retina of hatchling chicks. We tested whether colchicine
influences normal ocular growth and form-deprivation myopia, and whether it affects cells other than GCs. Colchicine greatly
increased axial length, equatorial diameter, eye weight, and myopic refractive error, while reducing corneal curvature. Colchicine
caused DNA fragmentation in many GCs and some amacrine cells and photoreceptors, ultimately leading to the destruction of
most GCs and particular sub-sets of amacrine cells. Colchicine-induced ocular growth may result from the destruction of amacrine
cells that normally suppress ocular growth, and corneal flattening may result from the destruction of GCs whose central pathway
normally plays a role in shaping the cornea. © 1998 Elsevier Science Ltd. All rights reserved.
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1. Introduction
The shape and size of the eye are crucial to the
quality of vision. Emmetropia is achieved when the
distance between the retina and the lens is matched to
the combined refractive power of the lens and cornea so
that distant images are focussed upon the retina with
accommodation relaxed. If the focal plane of an image
falls in front of the retina the eye is myopic (near-
sighted), whereas if the focal plane is behind the retina
the eye is hyperopic (far-sighted). Early in life, growth
of the eye is regulated precisely so that emmetropia is
achieved. The process of emmetropization can be per-
turbed by depriving the eye of patterned images, which
results in elongation of the vitreous chamber and my-
opia (Wallman, 1993). The paradigm of form-depriva-
tion myopia (FDM), commonly studied in chicks, has
provided ample evidence that visual experience is re-
quired to properly guide ocular growth and that this
regulation of growth is mediated by retinal activity
(Wallman, Gottlieb, Rajaram & Fugate-Wentzek, 1987;
Troilo, Gottlieb & Wallman, 1987).
One question that has been addressed by researchers
is whether accommodation and retinal connections to
the brain are required for emmetropization. Disabling
of accommodative mechanisms and interruption of reti-
nal connections to the brain by optic nerve section,
intravitreal application of tetrodotoxin, lesions to the
nucleus of Edinger-Westphal, removal of the ciliary
ganglion, or severing of the ciliary nerves have little or
no effect on emmetropization or FDM (Wallman,
Rosenthal, Adams & Romagnona, 1981; Troilo, Got-
tlieb & Wallman, 1987; Schaeffel, Glasser & Howland,
1988; Schaeffel, Troilo, Wallman & Howland, 1990;
Troilo, 1990; Lin & Stone, 1991; Troilo & Wallman,
1991; Wildsoet & Howland, 1991; McBrien, Moghad-
dam, Cottriall, Leech & Cornell, 1995). These findings
suggest that the mechanisms of visual guidance of
ocular growth are intrinsic to the eye and do not
require active accomodation or communication with
higher visual centers.
The purpose of this study was to explore another
model for removal of retinal input to the brain, and
thereby to test independently the hypothesis that retinal
connections to the brain are required to modulate
ocular growth. Colchicine has been reported to destroy
most retinal ganglion cells, while sparing intrinsic reti-
nal neurons (Morgan, 1981). Therefore, we injected
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colchicine into the eyes of newly hatched chicks, mea-
sured their refractive state and ocular dimensions 2
weeks after treatment, tested whether they could re-
spond to form-deprivation, and characterized damage
caused by colchicine using a variety of cytochemical
markers. Surprisingly, we found that colchicine caused
large increases in the size of eyes, comparable to those
caused by form-deprivation, accompanied by corneal
flattening. In addition, colchicine not only destroyed
ganglion cells but also amacrine cells, including some
that have been implicated in the visual regulation of
ocular growth. We conclude that colchicine not only
affects retinal ganglion cells, but also damages or de-
stroys specific subsets of retinal amacrine cells. It is
likely that some of the lesioned amacrine cells are
normally responsible for the visual control of vitreal
chamber elongation, whereas the ablated ganglion cells
control corneal shape via central and peripheral neural
pathways.
2. Material and methods
2.1. Animals
Newly hatched male leghorn chickens (Gallus gallus
domesticus) were obtained from Lillydale Hatchery
(Linden, Alberta) and kept on a cycle of 12 h light, 12
h dark (lights on at 07:00 h). Illumination was pro-
vided by 100 W incandescent light bulbs, resulting in
irradiance levels 50.8 cpd:m2, depending on the direc-
tion of gaze. Prior to experimentation, chicks were held
for 1 week in a stainless steel brooder, at about 25oC.
Chicks received water and Purina™ chick starter ad
libitum.
2.2. Intraocular injections
Chicks were anesthetized with 1.5% halothane in
50% N2O and 50% O2 prior to injection. Injections
were made into the vitreous chamber using a 25-ml
Hamilton syringe with a 26 gauge needle. Penetration
of the needle was consistently made into the dorsal
quadrant of the eye. Shortly after the chicks were
hatched, the right eye (control) was injected with 20 ml
of vehicle (sterile saline) and the left eye (treated) was
injected with 20 ml of sterile saline or 20 ml of 25 mM
(0.5 nmol or 0.2 mg) colchicine (Research Biochemicals
Internationl, Natick, MA). Assuming that the volume
of liquid-vitreous within an eye was 150 ml, the initial
maximum concentration of colchicine presented to the
retina was about 3 mM. One, 3 and 7 days later,
pupillary responses were tested by shining a flashlight
over the dark-adapted eye of the chick. Seven days
after treatment, eyes were either covered with a
translucent goggle or left open. At 7 days (i.e. before
form-deprivation) and 14 days of age (i.e. after form-
deprivation), eyes were refracted using a streak
retinoscope and trial lenses without cycloplegia or
anesthesia. At 14 days of age chicks were killed by
chloroform inhalation, eyes removed from the orbit,
and most of the attached connective tissues and mus-
cles trimmed away. Eyes were weighed (to the nearest
milligram) using a Mettler PL200 digital balance, and
the equatorial diameter (at the most narrow part of the
eye) and axial length (at the apex of the cornea to the
base of the posterior eye) were measured using digital
calipers.
2.3. Fixation and sectioning
Enucleated eyes were hemisected equatorially and
the gel vitreous removed from the posterior eye cup.
Eye cups were fixed for 30 min at 20oC in 4%
paraformaldehyde plus 3% sucrose in 0.1 M phosphate
buffer, pH 7.4. Some samples were fixed for 24 h at
4oC, since these conditions were better for immunola-
belling with antisera to GAD-65, GABA or serotonin.
Fixed samples were washed three times in PBS (phos-
phate-buffered saline; 0.05 M phosphate buffer, 195
mM NaCl, pH 7.4), cryoprotected in PBS plus 30%
sucrose, soaked in embedding medium (OCT-com-
pound; Tissue-Tek) for 10 min, and freeze-mounted
onto aluminum sectioning blocks. Vertical sections
nominally 12–14 mm thick were cut consistently from
the posterior pole of the eye in the nasotemporal plane,
near the dorsal portion of the pecten, and thaw-
mounted onto gelatin-coated glass slides. Sections from
control and treated eyes from the same individual were
placed consecutively on each slide to ensure equal
exposures to reagents. Sections were air-dried, ringed
with rubber cement, and stored at 20oC until use.
2.4. Immunocytochemistry
Sections were washed three times in PBS, covered
with primary antibody solution (Table 1; 150 ml of
antiserum diluted in PBS plus 5% normal goat serum,
0.3% Triton X-100, and 0.01% NaN3), and incubated
for about 24 h at 20oC in a humidified chamber. The
slides were washed three times in PBS, covered with
secondary antibody solution (150 ml of 1:1500 Cy3-
conjugated goat-anti-rabbit IgG or mouse IgG, Amer-
sham), and incubated for at least 2 h at 20oC in a
humidified chamber. Finally, samples were washed
three times in PBS, rubber cement removed from the
slides, and coverslips mounted on 4:1 (v:v) glycerol to
water for observation under an epifluorescence micro-
scope using a rhodamine filter combination. Photo-
graphs were taken on T-Max 400 film (Kodak) and
negatives developed in T-Max Developer (Kodak) as
per the manufacturer’s instructions.
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Table 1
Antisera
Source Working dilutionAntiserum Antigen Species:type
Dr J.H. Rogers 1:1000pURXR.3 Calretinin Rabbit polyclonal
Rabbit polyclonal Dr M. Epstein1465 Choline acetyltransferase (ChAT) 1:1000
Dr J.-M. FritschyMouse monoclonal 1:50GABAA receptorBD-17
1:1000Dr J. Walsh8305034 Glucagon Rabbit polyclonal
Rabbit polyclonal Dr C. Brandon634 Glutamic acid decarboxylase (GAD-65) 1:1000
Dr M. ChiquetMouse monoclonal 1:70Bipolar cell markerM3
Dr J. Walsh 1:10001473 Met-enkephalin (ENK) Rabbit polyclonal
1:50Hybridoma BankMouse monoclonalNeurofilament-associated antigen3A10
Mouse monoclonal SigmaP-3171 Parvalbumin 1:1600
Mouse monoclonal AmershamRPN536 Protein kinase C (PKC) a and b isoforms 1:50
1:800Inc StarRabbit polyclonalSerotonin (5-HT)5-HT
Transforming growth factor-b2 (TGF-b2) Rabbit polyclonal Santa Cruz 1:1000sc-90
1:1000Dr W. Tankc16 Tyrosine hydroxylase (TH) Rabbit polyclonal
1:80Vasoactive intestinal polypeptide (VIP) Rat monoclonalVP31 Dr A. Buchan
2.5. Histology
Slides were warmed to 20oC, washed three times in
PBS, and incubated under 200 ml 0.1% (w:v) toluidine
blue plus 0.2% (w:v) Na2B4O7 in dH2O at pH 11.4 for
about 2 min. The stain was drained away, slides washed
three times in PBS, and mounted, as described above,
for microscopy in transmitted white light.
2.6. Labelling of fragmented DNA
Retinal sections were obtained as described above
from chicks 1, 3, 5 and 7 days after colchicine-treat-
ment. Slides were warmed to 20oC and washed once in
PBS, followed by one wash in PBS plus 0.3% Triton
X-100, and two more washes in normal PBS. Sections
were then covered with 150 ml of incubation medium
(0.5 nmol Cy3-conjugated dCTP, 20 units of 3%-terminal
deoxynucleotidyl transferase (Amersham), 100 mM
sodium cacodylate, 2 mM CoCl2, and 0.25 mM b-mer-
captoethanol, in distilled water at pH 7.2) and incu-
bated for 1 h in a humidified chamber at 37oC. Sections
were then washed three times in PBS, mounted in 4:1
(v:v) glycerol to water, and coverslips added for obser-
vation by epifluorescence using a rhodamine filter
combination.
2.7. Measurements of corneal cur6ature
Photographs were made of enucleated eyes viewed
from the side. The negatives of these photographs were
digitized to a resolution of 20 pixels per mm. Using
Adobe Photoshop 4.0™, a rectangular area was
blocked out, with one corner originating at the apex of
the cornea while the opposing corner was set at the
base of the cornea. The number of pixels in the height
and width of the rectangle was then determined, and a
height to width ratio calculated as a function represen-
tative of corneal curvature.
2.8. Measurements, cell counts, and statistical analyses
Errors were calculated as the standard deviation of
each sample which was comprised of at least six indi-
viduals per group. To assess the differences between
data from treated and control eyes, we used a paired
two-tailed Student t-test. To assess the differences be-
tween eyes from multiple different treatments, we used
a two-way ANOVA (In Stat© for MacIntosh). Percent-
age IPL depth was calculated as the distance from the
border between the inner plexiform layer (IPL) and
inner nuclear layer (INL), divided by the total IPL
thickness, multiplied by 100. All thickness measure-
ments were made from photomicrographs of central
retina, while all cell counts of at least 50 cells per
individual on at least four different sections were made
under the microscope.
3. Results
3.1. Pupillary responses
One day after treatment with colchicine, all chicks
(n32) had pupillary responses, although the re-
sponses in treated eyes were slightly reduced. Three and
7 days after treatment, eyes injected with saline had
strong pupillary constriction when exposed to bright
light, while there was no response in colchicine-treated
eyes. Furthermore, by 3 days after treatment chicks
were blind in their treated eye, as they did not respond
to an approaching hand. All chicks were still able to
feed normally.
3.2. Changes in gross retinal morphology
Histological and immunocytochemical examinations
were made only 14 days after treatment, when the
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Fig. 1. Vertical sections of retina that have been stained with toluidine blue from (a) control and (b) colchicine-treated eyes. Abbreviations: IPL,
inner plexiform layer; INL, inner nuclear layer; GCL, ganglion cell layer. Scale bar50 mm.
colchicine-induced lesion should have been stabilized
(Morgan, 1981). Colchicine caused significant losses of
thickness from several retinal layers, particularly the
optic fibre layer (OFL) (28.796.2% of the control;
mean9S.D.; n8) and IPL (55.598.3% of the con-
trol). The thickness of the INL was also slightly re-
duced to 83.198.6% of the control. Colchicine caused
an obvious loss of cells and thickness from the ganglion
cell layer (GCL; Fig. 1); the majority of the cells
remaining were assumed to be displaced amacrine cells
(Morgan, 1981). The photoreceptor layer and retinal
pigmented epithelium (RPE) appeared dysplastic, thin
or discontinuous in some parts, while appearing thicker
in other regions (Fig. 1).
3.3. Effects of colchicine upon immunohistologically
distinct populations of retinal neurons
Colchicine caused no detectable loss in labelling in-
tensity or distribution of amacrine cells immunoreactive
for GAD-65, GABAA receptor, serotonin, parvalbu-
min, or PKC, except for the compression of neurites
within the thinned IPL. Colchicine had no apparent
effect upon bipolar cells labelled with monoclonal anti-
body M3 or antiserum to PKC, or upon nerve fibers in
the choroid that were immunoreactive for NAA,
ChAT, TH or VIP (results not shown).
3.4. Enkephalin
Antiserum to enkephalin (ENK) labelled many cells
having somata near the middle of the INL, and den-
drites in several distinct sublaminae of the IPL (Fig.
2a). These cells are the enkephalin-neurotensin-somato-
statin-like immunoreactive (ENSLI) amacrine cells
which have been described previously in avian retina
(Brecha, Karten & Laverack, 1979; Watt, Li & Lam,
1985; Morgan, Wellard & Boelen, 1994; Watt & Flo-
rack, 1994). After exposure to colchicine there was a
substantial loss of ENK-immunoreactive amacrine cells
(Fig. 2a), nearly half of which (45.1913.8%; n6)
perished after 14 days. The cells that survived appeared
normal, lacking noticeable swelling of their somata or
degeneration of terminal arbors (Fig. 2a).
3.5. Choline acetyltransferase
Antiserum to choline acetyltransferase (ChAT) la-
belled many orthotopic and displaced amacrine cells, as
well as two prominent strata in the IPL (Fig. 2b),
exactly as described previously (Millar, Ishimoto,
Chubb, Epstein, Johnson & Morgan, 1987). Subtypes
of cholinergic amacrine cells included: type-I cells, with
somata in the proximal INL and neurites in sublamina
2 of the IPL; type-II cells, with somata in the GCL and
neurites in sublamina 4 of the IPL; and type-III cells,
with somata near the middle of the INL and neurites
diffusely distributed in sublaminae 1 and 3–5 of the
IPL. As reported elsewhere, about half of the type-III
cells are ENSLI cells (Fischer, Poon, Seltner & Stell,
1998). Colchicine had no apparent effect upon type-I
and type-II cholinergic amacrine cells, while inducing
some loss of type-III cells (Fig. 2b). This was foreshad-
owed by the results of ENK-immunolabelling, in which
many type-III:ENSLI cells were destroyed by
colchicine.
3.6. Tyrosine hydroxylase
Antiserum to tyrosine hydroxylase (TH) labelled
sparsely distributed cell bodies with neurites in three
different strata in the IPL, at 0–10, 35, and 75% depth
(Fig. 2c), exactly as described previously (Su & Watt,
1987). Only about 10% (10.996.5%; n6) of TH-im-
munoreactive amacrine cells survived exposure to col-
chicine, and consequently there were massive losses of
TH-positive neurites from the IPL; this loss of TH-im-
munoreactive cells was uniform across the entire retina
(Fig. 2c).
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Fig. 2. Vertical sections of retinas that have been treated with saline (left panel) or colchicine (right panel) and labelled with antibodies directed
against (a) enkephalin; (b) choline acetyltransferase; (c) tyrosine hydoxylase; (d) vasoactive intestinal polypeptide; (e) glucagon; (f) calretinin; (g)
neurofilament-associated antigen; and (h) transforming growth factor-b2. Large arrow heads indicate the inner limiting membrane and small
arrow heads indicate the proximal and distal borders of the IPL. Abbreviations: IPL, inner plexiform layer; INL, inner nuclear layer; GCL,
ganglion cell layer. Scale bar50 mm.
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Fig. 2. (Continued)
3.7. Vasoacti6e intestinal polypeptide
Antiserum to vasoactive intestinal polypeptide (VIP)
labelled puncta in the perinuclear cytoplasm of many
cell bodies near the border of the INL and IPL, in
addition to sparsely distributed neurites at 0–10, 35,
and 70% IPL depth, as described previously (Fig. 2d;
Brecha, 1983; Seltner & Stell, 1995). Colchicine caused
a substantial loss of VIP-containing cell bodies in the
INL and neurites in the IPL (Fig. 2d).
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3.8. Glucagon
Antiserum to glucagon labelled amacrine cells having
somata at the IPL:INL border, one densely innervated
stratum at 0–10% IPL depth, and one sparsely inner-
vated stratum at 35% IPL depth (Fig. 2e), as described
previously (Kiyama, Katayama-Kumoi, Kimmel, Stein-
busch, Powell, Smith & Tohyama, 1985). More than
90% (90.991.0%; n6) of glucagon-immunoreactive
amacrine cells were destroyed by colchicine, leaving very
few glucagon-containing neurites in the IPL; this loss of
glucagon-immunoreactive cells was uniform across the
entire retina (Fig. 2e).
3.9. Calretinin
Antiserum to calretinin labelled most cells in the GCL,
amacrine cells, and horizontal cells, as well as a subset
of bipolar cells with somata located towards the middle
of the INL (Fig. 2f). Both plexiform layers and the OFL
were filled with dendrites and:or axons that were im-
munoreactive for calretinin. Calretinin-immunoreactiv-
ity could be distinguished in at least 12 strata within the
IPL (Fig. 2f). This distribution of calretinin is consistent
with previous reports (Ellis, Richards & Rogers, 1991;
Rogers, Khan & Ellis, 1989; Rogers, 1989). Two weeks
after exposure to colchicine, little or no calretinin im-
munoreactivity remained in the GCL and OFL (Fig. 2f).
This suggests that the type-II cholinergic cells displaced
to the GCL, which were unaffected by colchicine, are not
immunoreactive for calretinin. Colchicine had little or
no effect upon calretinin-immunoreactive horizontal,
bipolar, and amacrine cells. Furthermore, there ap-
peared to be little change in the distribution of calretinin-
immunoreactivity in the IPL and OPL, except for the
compression of strata in the thinned IPL.
3.10. Neurofilament-associated antigen (NAA)
Antiserum to neurofilament-associated antigen
(NAA) robustly labelled the axons of ganglion cells in
the OFL and of displaced ganglion cells or efferent
target cells at the INL:IPL border (Fig. 2g). In control
retinas, all ganglion cells were only weakly immunoreac-
tive for NAA (results not shown). Colchicine caused a
massive loss of NAA-immunoreactivity from the OFL
and significant depletion of NAA-immunoreactive fibres
at the INL:IPL border (Fig. 2g). The few ganglion cells
that survived exposure to colchicine became hyperim-
munoreactive for NAA and often appeared swollen and
abnormal (Fig. 2g).
3.11. Transforming growth factor-b2 (TGF-b2)
Antiserum to transforming growth factor-b2 (TGF-
b2) labelled sparsely distributed amacrine cells, with
somata located near the border of the IPL and INL, and
most cells in the GCL (Fig. 2h), as observed previously
(Gudgeon, Fischer & Stell, 1998). Colchicine had no
effect upon TGF-b2-immunoreactive amacrine cells, but
abolished most TGF-b2-immunoreactivity in the GCL
(Fig. 2h). Surviving ganglion cells became hyperim-
munoreactive for TGF-b2 and often appeared swollen
and abnormal (Fig. 2h).
3.12. Colchicine-induced DNA fragmentation
Twenty-four hours after exposure to colchicine there
was no detectable DNA fragmentation in treated retinas.
Fig. 3. Vertical sections of retinas treated with colchicine and labelled
for DNA fragmentation (a) before, and (b) 3 and (c) 5 days after
treatment. Abbreviations: IPL, inner plexiform layer; INL, inner
nuclear layer; GCL, ganglion cell layer; ONL, outer nuclear layer.
Scale bar50 mm.
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However, 3 days after treatment the nuclei of many
amacrine cells were labelled for fragmented DNA,
while only a few nuclei of photoreceptors and ganglion
cells were labelled (Fig. 3b). Five days after treatment,
fragmented DNA was detected in the nuclei of many
ganglion cells and a few amacrine cells, but was no
longer present in the nuclei of photoreceptors (Fig. 3c).
Seven days after treatment, fragmented DNA was no
longer detected in any retinal cells (results not shown).
3.13. Ocular growth in colchicine-treated eyes
Fourteen days after treatment with colchicine, eyes
had grown excessively and become myopic. In compari-
son to control eyes, the axial length, equatorial diame-
ter, weight, and negative refractive error were
significantly (PB0.0001) greater in treated eyes (Fig.
4). On average, colchicine-treated eyes were 10.292.9%
longer, 5.091.9% wider, and weighed 20.694.9%
more than contralateral control eyes. These increases in
eye size were not significantly different from the in-
creases caused by 7 days of form-deprivation of saline-
injected control eyes (Fig. 4). However, the amount of
myopia that resulted from colchicine treatment was
significantly (P0.0006) less than that caused by form-
deprivation. Furthermore, form-deprivation did not
further increase eye size or refractive error caused by
colchicine (Fig. 4). Colchicine also caused significant
(P0.0001; n7) flattening of the cornea (Fig. 5). The
height to width ratio of corneas from saline-injected
eyes was 0.64590.056 (n7), while that of corneas
from colchicine-treated eyes was 0.49490.044 (n7).
The height of treated corneas was 39.098.3% less than
that of controls.
4. Discussion
4.1. Colchicine-induced ocular enlargement
Colchicine-treated eyes received normal visual stim-
uli, which are required for normal growth of the eye,
but were unable to emmetropize. Therefore, among the
damage elicited by colchicine was the disruption of
pathways that promote emmetropization. Colchicine
also resulted in the activation of growth-promoting
pathways or the destruction of growth-suppressing
pathways, thereby allowing ocular growth to run
unchecked or by default. These changes in ocular
growth may have been caused by colchicine-induced
damage to the RPE, photoreceptors, ganglion cells,
and:or subsets of amacrine cells, or by undetected
damage to ocular tissues.
Colchicine-treated retinas were unable to send the
brain normal information regarding the visual environ-
ment, because of the destruction of most ganglion cells.
It is unlikely that this loss of ganglion cells caused
excessive growth or prevented emmetropization, as op-
tic nerve sectioning also causes destruction of most
ganglion cells but has little effect upon normal ocular
growth or FDM (McBrien, Moghaddam, Cottriall,
Leech & Cornell, 1995; Troilo, Gottlieb & Wallman,
1987; Wildsoet & Pettigrew, 1988). In fact, lesioning of
the optic nerve results in smaller, hyperopic eyes
(Troilo, Gottlieb & Wallman, 1987), although it is not
clear whether this is caused by loss of ganglion cell
input to the brain or damage to intrinsic retinal circuits
due to surgery.
Colchicine also damaged or destroyed some photore-
ceptors. It is unlikely that photoreceptors participate
directly in the visual modulation of ocular growth,
although damage to photoreceptors that activate pref-
erentially a critical subset of retinal pathways might in
principle disrupt emmetropization. Furthermore, the
destruction of many photoreceptors with tunicamycin
does not affect normal eye growth or the progression of
FDM (Ehrlich, Sattayasai, Zappia & Barrington, 1990).
The destruction of photoreceptors and the RPE with
formoguanamine also does not affect normal eye
growth, but does prevent FDM (Oishi & Lauber, 1988).
Therefore, it is unlikely that colchicine-induced damage
to photoreceptors caused excessive ocular growth or the
inability of treated eyes to emmetropize.
The accelerated ocular growth caused by colchicine
may have resulted from the destruction of retinal
amacrine cells. It is possible that the normal suppressive
control of ocular growth requires the activity of
amacrine cells that are affected by colchicine, including
those that contain VIP, enkephalin and ChAT, TH or
glucagon, or other amacrine cells for which we did not
probe. Pharmacological studies have implicated several
subsets of amacrine cells in the progression of FDM,
including those that produce dopamine (Stone, Lin,
Laties & Iuvone, 1989), VIP (Stone, Laties, Raviola &
Weisel, 1988; Seltner & Stell, 1995), ENK (Seltner,
Rohrer, Grant & Stell, 1997), and acetylcholine (Stone,
Lin & Laties, 1991; McBrien, Moghaddam & Reeder,
1993; Leech, Cottriall & McBrien, 1995). These studies
have suggested that retinal cells that release VIP, ENK
or acetylcholine promote ocular growth during form-
deprivation, while cells that release dopamine suppress
growth. However, in the quisqualate-treated retina,
cells containing VIP, ENK or acetylcholine are com-
pletely destroyed, yet these eyes remain emmetropic and
are capable of responding to form-deprivation, thereby
suggesting that these cells do not contribute to visually
guided ocular growth (Fischer, Poon, Seltner & Stell,
1998; Fischer, Miethke, Morgan & Stell, 1998). In
contrast, glucagon and TH-immunoreactive amacrine
cells are relatively unaffected by quisqualate (Fischer,
Poon, Seltner & Stell, 1998), but are eliminated from
colchicine-treated retinas (present study). There is no
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Fig. 4. Colchicine-induced changes in (a) axial length; (b) equatorial diameter; (c) refractive error; and (d) eye weight. Significance (*PB0.0001)
of difference between means of treated samples and controls was assessed by using a one-way Student t-test. Abbreviation: FD, form-deprived.
evidence that glucagon-immunoreactive amacrine cells
modulate ocular growth. The evidence for a role of
dopamine and TH-immunoreactive cells in growth-reg-
ulation and FDM is mixed, but the concurrent destruc-
tion of TH cells and induction of ocular enlargement by
colchicine is consistent with other evidence favoring
such a role (Stone, Lin, Laties & Iuvone, 1989; Rohrer,
Spira & Stell, 1993).
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Fig. 5. Photographs of eyes that have been treated with (a & c) saline; (b) form-deprived; or (d) treated with colchicine. Scale bar5 mm.
Alternatively, colchicine may have destroyed or influ-
enced the activity of cells in the choroid or sclera that
normally suppress ocular growth. However, it is coun-
ter-intuitive to expect that colchicine-induced destruc-
tion or suppression of normal cellular activities, such as
mitosis or secretion of synthesized products, could re-
sult in excessive ocular growth. It also seems unlikely
that a single dose of colchicine could elicit an effect
over the 2-week observation period used in our experi-
ments unless there was a permanent removal of cells
without any replacement.
Form-deprivation did not further enhance the nega-
tive refractive error or the increased size of colchicine-
treated eyes. It is possible that the mechanisms that
promote ocular growth were ‘saturated’ in both form-
deprived and colchicine-treated eyes, so that maximum
rates of growth occurred in both conditions. If maxi-
mum rates of growth were achieved in both form-de-
prived and colchicine-treated eyes, then eyes should
have been equally large for both treatments, and form-
deprivation of colchicine-treated eyes should not have
resulted in further enhancement of eye size. Indeed, we
found that the size of eyes that were form-deprived,
colchicine-treated, and colchicine-treated and form-de-
prived were nearly equivalent. This suggests that col-
chicine and form-deprivation activate the same
mechanism that enhances ocular growth. Alternatively,
growth-promoting mechanisms may not have been sat-
urated, and colchicine may have destroyed the retinal
circuitry responsible for form-deprivation-induced
growth, thereby rendering the treated eyes unresponsive
to form-deprivation.
4.2. Colchicine-induced corneal flattening
Colchicine caused a pronounced flattening of the
cornea. This accounted at least in part for the smaller
degree of myopia in colchicine-treated open eyes than
in saline-treated form-deprived eyes, as the ocular di-
mensions of these eyes were not significantly different
and in themselves should have produced similar refrac-
tive errors. Flattening of the cornea would result in
reduced refractive power, thereby decreasing the refrac-
tive error of these enlarged eyes. It is also possible that
choroidal thickening (Wallman, Wildsoet, Xu, Gottlieb,
Nickla, Marran, Krebs & Christensen, 1995; Wildsoet
& Wallman 1995) could have decreased refractive error
of colchicine-treated eyes, but this possibility was not
tested in these experiments.
Corneal flattening may have resulted from the col-
chicine-induced loss of ganglion cells. Flattening of the
cornea was observed by Troilo & Wallman (1991) after
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optic nerve sectioning, and by McBrien, Moghaddam,
Cottriall, Leech & Cornell (1995) after chronic ad-
ministration of tetrodotoxin. Although colchicine,
tetrodotoxin, and optic nerve lesioning all elicit differ-
ent effects and may perturb different functions within
the eye, they share suppression or abolition of gan-
glion cell activity and transmission to the brain.
Therefore, we propose that corneal growth is regu-
lated by activity in one or more classes of retinal
ganglion cell, presumably through some visual cen-
ter(s) in the brain and outflow via the cilary ganglion
and nerves.
4.3. Colchicine-induced destruction of retinal cells
The mechanisms underlying the destruction of reti-
nal cells by colchicine remain uncertain. Fragmented
DNA was detected in both amacrine and ganglion
cells, suggesting that these cells became apoptotic af-
ter exposure to colchicine. Colchicine causes the dis-
assembly of microtubules, and thereby interferes with
many cellular functions. One function disrupted by
colchicine is axonal transport (Hanson & Edstro¨m,
1978), and ganglion cells might be expected to perish
because both anterograde and retrograde transport
(e.g. of trophic factors) were disabled. The reduction
in effect of colchicine in the eyes of older chicks
(Morgan, 1981), might reflect a reduced trophic de-
pendency. However, in the chick, natural death of
retinal ganglion cells and establishment of retinotectal
connections occur before hatching (Rager, 1976;
Rager & Rager, 1978; Rager & Oeynehausen, 1979).
Competition for trophic targets would, therefore, be
completed long before we observed colchicine-induced
cell death. This does not, however, exclude the possi-
bility that these cells have a continued trophic depen-
dency after tectal connections have been established.
This in fact is likely, since axotomy usually results in
the death of ganglion cells (Bray, Villegas-Perez, Vi-
dal-Sanz, Carter & Aguayo, 1991).
Colchicine probably prevented the anterograde
transport of proteins away from the cell bodies of
residual ganglion cells. The accumulation of NAA
and TGF-b2-immunoreactivity in some ganglion cells
after exposure to colchicine suggests that protein syn-
thesis was unaffected while the transport of synthe-
sized products away from the cell body was disabled.
Residual ganglion cells are likely to be non-functional
or dysfunctional, as axonal transportation was pre-
vented. The consequent accumulation of TGF-b2-im-
munoreactivity in ganglion cell bodies implies that
TGF-b2 is normally exported out of the retina along
axons, or into the IPL in dendrites. It has been ar-
gued that the blockade of anterograde transport and
subsequent build-up of proteins in cell bodies results
in apoptosis and that this is somehow related to the
degree of axon myelination and requirements for the
exchange of lipid materials between axons and oligo-
dendrocytes (Droz, 1979; Morgan, 1981).
It remains uncertain why only certain sub-popula-
tions of amacrine cells perished after exposure to col-
chicine. There is no precedent for dependence of
intrinsic retinal neurons on cytoplasmic transport of
trophic factors. However, there is also no evidence
against such dependence and thus we cannot exclude
the possiblity that colchicine caused the death of
amacrine cells by depriving them of retrogradedly
transported trophic factors. All types of amacrine
cells that were affected by colchicine, in particular the
strongly affected TH and glucagon-immunoreactive
cells, had broad dendritic arbors. It is possible that
the wide dendritic arbors and consequently increased
requirements for anterograde and retrograde transport
rendered these amacrine cells more susceptible to col-
chicine-induced cell death. For example, colchicine-in-
duced cytoskeletal alterations in rat cerebellar granule
cells have been postulated to directly initiate apopto-
sis (Bonofoco, Ceccatelli, Manzo & Nicotera, 1995).
4.4. Summary and conclusions
Colchicine destroyed most ganglion cells, as well as
subtypes of amacrine cells including those thought to
participate in visual guidance of ocular growth. Col-
chicine also damaged the RPE and photoreceptors.
As a result of the damage caused by colchicine, eyes
were unable to emmetropize, grew excessively, became
myopic, and had flattened corneas. We propose that
colchicine-induced elongation of the vitreous chamber
results from the destruction of one or more subsets of
amacrine cells that normally suppress growth in re-
sponse to visual stimuli, and that colchicine-induced
corneal flattening results from the destruction of one
or more subsets of ganglion cells that normally pro-
mote proper corneal shape.
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